Skip to content

Comparison of the Effects of Balance-proprioception and Aerobic Exercises on Functional Status and Strength Parameters in Patients With Fibromyalgia.

Comparison of the Effects of Balance-proprioception and Aerobic Exercises on Functional Status, Pain and Strength Parameters in Patients With Fibromyalgia Syndrome (FMS).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04437524
Acronym
FMS
Enrollment
51
Registered
2020-06-18
Start date
2020-08-24
Completion date
2020-11-30
Last updated
2020-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Syndrome

Keywords

Fibromyalgia, aerobic exercise, balance, proprioception, pain, strength

Brief summary

In this study, it was aimed to examine the effects of aerobic exercise and balance-proprioception exercises on pain, functionality and strength parameters of fibromyalgia patients and to compare the two exercise types.

Detailed description

In the study planned to evaluate the effect of aerobic and balance-proprioception exercises on the symptoms of the disease and the superiority of the two exercise models in patients with fibromyalgia syndrom (FMS), 62 women who meet the inclusion criteria will be randomly divided into two groups. Aerobic exercise group (n = 26) and balance-proprioception exercise group (n = 26) will be applied for 3 weeks a week, 6 days a week under the supervision of a physiotherapist in the exercise laboratory of the Istanbul Medical Faculty Sports Medicine Department. Pain (VAS), functional status (FİQ) and knee extension muscle strength (Cybex isokinetic dynamometer) will be evaluated before and after the program. Cognitive status will be evaluated with standardized Mini Mental Test only before the program.

Interventions

OTHERtherapeutic exercises

Treatment that will continue 3 days a week for 6 weeks in female patients with fibromyalgia.

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Being between the ages of 18 and 60, * Symptoms lasting longer than 3 months, * According to the 2013 ACR criteria, the Pain Settlement Score (PLI) is ≥17, * According to the 2013 ACR criteria, the Symptomatic Impact Scoring (SIQR) is ≥21, * Acceptance of treatment that will continue 3 days a week for 6 weeks, * The possibility of any change in medical treatment due to FMS during the study is not foreseen.

Exclusion criteria

* Known central or peripheral nervous system disease, progressive neurological damage, * Any serious cardiovascular pathology, * Sense, loss of sense of position, unhealed fracture or a surgical wound, * Presence of uncontrolled hypertension, * Failure to understand or perform simple commands.

Design outcomes

Primary

MeasureTime frameDescription
Fibromyalgia Impact Questionnaire (FIQ)6 weeksIn order to evaluate the functional status in patients with FMS, FIQ Burchardt et al. It is a specific scale developed by. FIQ consists of 10 items. Calculation is made so that the upper limit of each item is 10 points. The maximum score that can be reached is 100. A high total score indicates that the person is more affected by the disease.
Pain (Visual Analogue Scale)6 weeksVisual Analaog Scale is used to measure the severity of pain in patients. The patient is told that there is no 0 pain on the 10 cm ruler drawn on paper, 10 is the most experienced pain, and the patient is asked to mark on the ruler according to the severity of the pain he/she feels. The distance of the marked point from zero is recorded as the Visual Analogue Scale score in cm.
Muscle Strength Evaluation6 weeksThe CSMI Humac Norm 2015 isokinetic dynamometer will be used to evaluate muscle strength.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026